Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Farheen Mir"'
Autor:
Carla Casulo, Michael Herold, Wolfgang Hiddemann, Sunil Iyengar, Robert E. Marcus, John F. Seymour, Aino Launonen, Andrea Knapp, Tina G. Nielsen, Farheen Mir
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:40-48
Although advanced‑stage follicular lymphoma (FL) is considered incurable, survival has improved with the introduction of the anti-CD20 antibodies, rituximab (R) and obinutuzumab (G). However, FL can undergo histological transformation (HT) to a mor
Autor:
Andrea Knapp, Tarec Christoffer El-Galaly, Michael Wenger, Judith Trotman, Michel Meignan, Tina Nielsen, Farheen Mir, Lale Kostakoglu, Sally F. Barrington, Denis Sahin
Publikováno v:
J Nucl Med
Barrington, S F, Mir, F, El-Galaly, T C, Knapp, A, Nielsen, T G, Sahin, D, Wenger, M, Kostakoglu, L, Trotman, J & Meignan, M 2022, ' Follicular lymphoma treated with first-line immunochemotherapy : A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study ', Journal of Nuclear Medicine, vol. 63, no. 8, pp. 1149-1154 . https://doi.org/10.2967/jnumed.121.262869
Barrington, S F, Mir, F, El-Galaly, T C, Knapp, A, Nielsen, T G, Sahin, D, Wenger, M, Kostakoglu, L, Trotman, J & Meignan, M 2022, ' Follicular lymphoma treated with first-line immunochemotherapy : A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study ', Journal of Nuclear Medicine, vol. 63, no. 8, pp. 1149-1154 . https://doi.org/10.2967/jnumed.121.262869
Complete metabolic response (CMR) on positron emission tomography-computed tomography (PET-CT) was the sole independent predictor of overall survival in the PET sub-study of the phase III GALLIUM trial (NCT01332968) in first-line treatment of high tu
Autor:
Christopher Rushton, Wolfram Klapper, Jonathan C. Strefford, Cathy Burton, Mark S. Cragg, Ryan D. Morin, Stephen A. Beers, Andrea Knapp, Malgorzata Nowicka, Christopher R. Bolen, Chern Lee, Chantal E. Hargreaves, Laura K. Hilton, Pedro Farinha, Matthew J. Carter, Margaret Ashton-Key, Matthew J. J. Rose-Zerilli, Kathleen N. Potter, Graham W. Slack, Maurizio Martelli, Christian Klein, Mikkel Z. Oestergaard, Umberto Vitolo, Laurie H. Sehn, Farheen Mir, Marek Trneny, Russell Foxall, David W. Scott
Publikováno v:
Blood Adv
Fc γ receptor IIB (FcγRIIB) is an inhibitory molecule capable of reducing antibody immunotherapy efficacy. We hypothesized its expression could confer resistance in patients with diffuse large B-cell lymphoma (DLBCL) treated with anti-CD20 monoclon
Autor:
Robert Marcus, Christopher R. Bolen, Sarah Huet, Farheen Mir, Michael Herold, Gilles Salles, Wolfram Klapper, Wolfgang Hiddemann, Mikkel Z. Oestergaard, Tina Nielsen, Jeffrey M. Venstrom, Oliver Weigert, Federico Mattiello
Publikováno v:
Blood
Autor:
Farheen Mir, Anna Robinson, Mark Edward Ethell, Michael Potter, Emma Nicholson, Chloe Anthias, Sandra Easdale, Carlos Gonzalez-Arias, Amit Sud, Claire E. Dearden, Ian Chau, David Cunningham, Dima El-Sharkawi, Bhupinder Sharma, Sunil Iyengar
Publikováno v:
Blood. 140:9366-9367
Autor:
Marek Trněný, Kathryn Humphrey, Nathalie A. Johnson, Sven de Vos, Gilles Salles, Farheen Mir, Richard Greil, Yanwen Jiang, Elizabeth Punnoose, Robin Gasiorowski, Arijit Sinha, Su Y. Kim, Caterina Patti, Emma Clark, Andrew D. Zelenetz, Jean-François Larouche, Nathalie Spielewoy, Divya Samineni, Alexandra Bazeos, Franck Morschhauser, Pierre Feugier, Pieternella J. Lugtenburg, Árpád Illés, Ian W. Flinn
Publikováno v:
Blood, 137(5), 600-609. American Society of Hematology
Blood
Blood
The phase 2 CAVALLI (NCT02055820) study assessed efficacy and safety of venetoclax, a selective B-cell lymphoma-2 (Bcl-2) inhibitor, with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in first-line (1L) diffuse la
Autor:
Sally F. Barrington, Tina Nielsen, Helen Brown, Farheen Mir, Judith Trotman, Deniz Sahin, Michel Meignan
Publikováno v:
Blood. 135:1214-1218
A minority of patients with follicular lymphoma (FL) undergo histological transformation (HT). This retrospective analysis of 549 patients from the phase 3 GALLIUM study (NCT01332968) assessed the relationship between maximum standardized uptake valu
Autor:
Naami Charlotte Mcaddy, Kabir Mohammed, Bhupinder Sharma, Sarah Thompson, Ian Chau, Farheen Mir, Larissa Sena, David Cunningham, Claire Dearden, Ayoma D. Attygalle, Sunil Iyengar, Andrew Wotherspoon, Katherine Vroobel, Nicos Fotiadis, Nicholas Butterfield, Indu Mitra, Charlotte Wilding, Dima El-Sharkawi
Publikováno v:
British Journal of Haematology. 189
Autor:
Wolfgang Hiddemann, Carla Casulo, Federico Mattiello, Robert Marcus, Andrea Knapp, Christopher R. Bolen, Michael Herold, John F Seymour, Farheen Mir, Andrew Grigg, Tina Nielsen
Publikováno v:
American Journal of Hematology
Patients with advanced‐stage follicular lymphoma (FL) who progress early after receiving first‐line therapy have poor overall survival (OS). Currently applied clinical prognostic models such as FL International Prognostic Index [FLIPI], FLIPI‐2
Autor:
Ian W. Flinn, Nathalie Spielewoy, F. Morschhauser, Robin Gasiorowski, S. de Vos, Marek Trněný, Richard Greil, Gilles Salles, Martin Kornacker, Jean-François Larouche, Arijit Sinha, P. Feugier, Farheen Mir, Elizabeth Punnoose, Árpád Illés, Nathalie A. Johnson, Caterina Patti, Pieternella J. Lugtenburg, Adam M. Petrich, Andrew D. Zelenetz, Divya Samineni, Alexandra Bazeos, Kathryn Humphrey, Edith Szafer-Glusman
Publikováno v:
Hematological Oncology. 37:135-137